Sentiment Trading

LakeShore Biopharma Co Ltd has received a preliminary non-binding proposal from Oceanpine Capital to be acquired at $0.86 per share, a 10.3% premium over its last closing price.

Ascelia Pharma AB is nearing completion of its New Drug Application (NDA) for Orviglance, a medication for treating liver metastases and gastric cancer, with submission expected by the end of August or early September.

GuangYuYuan Chinese Herbal Medicine Co Ltd reported a 28.95% year-over-year increase in net profit to 76.85 million CNY in the first half of 2025, driven by a 18.14% rise in total revenue.

Tianjin Pharmaceutical Da Re Tang Group Corp Ltd is a leading pharmaceutical company in China, with a diverse portfolio, strategic partnerships, and a strong financial foundation, positioning it for sustained growth and success in the global market.

Chimin Health Management Co Ltd, a Chinese pharmaceutical company, operates on the Shanghai Stock Exchange, with its stock experiencing recent volatility amidst a dynamic market.

WuXi AppTec Co Ltd is a key player in the AI-driven healthcare revolution, leveraging its comprehensive suite of products and services to capitalize on the growing convergence of healthcare and technology.

ALT5 Sigma Corp has appointed Jonathan Hugh as its new Chief Financial Officer, bringing 25 years of experience to help the company navigate financial and regulatory challenges in the health care and crypto sectors.

Enlivex Therapeutics Ltd is a clinical-stage biopharmaceutical company pioneering allogeneic therapies to address immune hyper-responses, with a promising pipeline and significant potential for future growth.

Green Thumb Industries Inc. is a leading pharmaceutical company specializing in medical marijuana and cannabis products, with a significant market presence and substantial market capitalization of $5.35 billion.

Prime Medicine, Inc. is a leading biotech company specializing in gene editing technology, making significant strides in the healthcare sector while navigating regulatory challenges and financial growth.